Free Trial
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel
NASDAQ:DH

Definitive Healthcare Q3 2026 Earnings Date & Estimates

Definitive Healthcare logo
$0.98 0.00 (-0.38%)
Closing price 10/12/2026 04:00 PM Eastern
Extended Trading
$0.98 0.00 (-0.03%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Definitive Healthcare is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for 5:00 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
5:00 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Definitive Healthcare in Q3 2026

Definitive Healthcare is expected to post earnings of $0.04 per share on revenue of $54.57 million. In the same quarter a year earlier Definitive Healthcare reported $0.07 per share on revenue of $60.05 million. Definitive Healthcare last reported on August 10, 2026, posting $0.05 per share and beating the $0.0427 consensus estimate. Definitive Healthcare has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.04
Expected Revenue
$54.57 million
Prior-Year EPS
$0.07
Prior-Year Revenue
$60.05 million
Expected EPS Growth
-42.9%
Expected Revenue Growth
-9.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.05 (Beat by +$0.0073)
Last Quarter Revenue
$55.20 million
EPS Beat Rate
5 of last 8 quarters

Prepare for the Q3 2026 Call

Definitive Healthcare Q3 2026 Earnings FAQ

Definitive Healthcare (NASDAQ:DH) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Definitive Healthcare's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Definitive Healthcare to post earnings of $0.04 per share for Q3 2026.

The consensus revenue estimate for Definitive Healthcare is $54.57 million for Q3 2026.

Definitive Healthcare Earnings Headlines

Definitive Healthcare Corp. (NASDAQ:DH) Stock Now Rated "Reduce" by Wall Street Brokerages
October 10 at 2:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31104845
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
October 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/01/3372995/0/en/definitive-healthcare-joins-the-network-advertising-initiative-to-strengthen-data-privacy-compliance-in-healthcare-marketing.html
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
 |  Stansberry Research (Ad)
Definitive Healthcare Corp.(NasdaqGS:DH) dropped from S&P Global BMI Index
September 20, 2026  |  marketscreener.comM
Analysts Conflicted on These Healthcare Names: Teva Pharmaceutical (TEVA) and Definitive Healthcare Corp (DH)
September 5, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TEVA/pressreleases/4459324/analysts-conflicted-on-these-healthcare-names-teva-pharmaceutical-teva-and-definitive-healthcare-corp-dh/
Analysts Are Bullish on Top Healthcare Stocks: Summit Therapeutics (SMMT), Definitive Healthcare Corp (DH)
September 4, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TEVA/pressreleases/4445041/analysts-are-bullish-on-top-healthcare-stocks-summit-therapeutics-smmt-definitive-healthcare-corp-dh/
See More Definitive Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Definitive Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Definitive Healthcare and other key companies, straight to your email.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a healthcare commercial intelligence company that provides data, analytics and software to help organizations understand the healthcare market. Its platform is designed to support decision-making across areas such as sales and marketing, market access, provider network strategy, competitive intelligence and healthcare operations.

The company’s products combine information on healthcare providers, hospitals, health systems, medical groups, payers, procedures and related market activity. Its offerings are used by pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, technology companies and other healthcare services organizations to identify opportunities, evaluate markets, manage customer and provider relationships, and improve commercial effectiveness.

Definitive Healthcare was founded in 2011 and is headquartered in Framingham, Massachusetts. The company serves customers primarily in the United States while also supporting organizations operating across broader healthcare and life sciences markets. Its shares began trading on the Nasdaq under the symbol DH in 2021.

View Definitive Healthcare Profile
Earnings Tools